Democratic Republic of Congo and the United States have reached an agreement on a strategic health partnership valued at $1.2 billion
The Democratic Republic of Congo and the United States have announced a strategic health partnership valued at $1.2 billion, according to a joint statement released by the two governments on Thursday.
The statement indicated that the partnership spans from 2026 to 2031. It encompasses $900 million in specific U.S. government aid and $300 million in “progressively increased domestic health expenditure” by the government of Congo, they stated.
The focus will be on HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome), tuberculosis, malaria, maternal and child health, polio eradication, epidemiological surveillance, health workforce development, and emergency preparedness and response, according to the statement. “This structural investment seeks to enhance the resilience of the healthcare system, improve care for the population, and reinforce the country’s healthcare sovereignty,” the ministry stated on X.
The structure of the DRC deal, which includes a requirement for domestic funding, aligns with the model that the U.S. has employed in various other health partnerships across Africa, although some of these have faced challenges recently.
On Wednesday, Zimbabwe withdrew from discussions regarding a $367 million bilateral health agreement with the U.S. This decision stemmed from worries about the sharing of sensitive health data in exchange for U.S. financial assistance, with a government spokesman indicating that the proposal constituted an “unequal exchange.”
Late last year, a Kenyan court put a hold on a health funding agreement exceeding $1.6 billion that the government had signed with the U.S. A consumer protection group brought a case that raised concerns about the safety of citizens’ health data, leading to this suspension.
